medigraphic.com
ISSN 1028-9933 (Electronic)

2017, Number 3

<< Back Next >>

RIC 2017; 96 (3)

Behavior of organic cytology in University Polyclinic 'Hermanos Martínez Tamayo' of Baracoa

Vega LY, Isaac GE, Durán RR, Castillo PY, Leyva FE

Language: Spanish
References: 16
Page: 363-373
PDF size: 180.90 Kb.


ABSTRACT

A retrospective, cross-sectional, analytical study was carried out with the objective of informing in the behavior of organic cytology and premalignant lesions according to the Early Detection of Cervical Cancer Program at the "Hermanos Martínez Tamayo" University Polyclinic in January-December 2016. The universe consisted of 2 568 women who underwent cytology according to non-use in organic cytology, alterations according to age groups and the existence of materials and equipment for performing cytologies in the workplace in the study period. Compliance with smears for new cases and re-examination is met in new cases. Useful cytologies predominated, whereas in the patients aged 30-34 years, altered cytologies predominated, at the same age, combinations of HPV and dysplasias, too. Prevalence of non-useful cytology in the highest percent of cases together with premalignant lesions followed by CIN I and HPV.


REFERENCES

  1. Ferlay J, Shin HR. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cáncer [Internet]. 2010 [citado 28 Oct 2016]; 127(12): [aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/21351269

  2. Sahara buddhe VV, Parham GP, Mwanahamuntu MH. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila) [Internet]. 2012 [citado 28 Oct 2016]; 5(1): [aprox. 3 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Cervical+cancer+prev ention+in+low-+and+middleincome+ countries%3A+feabsible%2C+affordable%2C+essential

  3. Forouzanfar MH1, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis Lancet [Internet]. 2011 [citado 2 Nov2016]; 378(9801): [aprox. 4 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Breast+and+cervical+ cancer+in+187+countries+between+1980+and+2010%3A+a+syste matic+analysis

  4. Loria D, Lence Anta JJ, Guerra Yí ME, Galán Álvarez Y, Barrios Herrera E, Alonso Barbeito R et al. Tendencia de la mortalidad por cáncer en Argentina, Cuba y Uruguay en un período de 15 años. Rev Cubana Salud Púb [Internet]. 2010 [citado 2 Nov 2016]; 36(2):[aprox.2p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662010000200004&lng=es

  5. Wiesner Ceballos C, Vejarano Velandia M, Caicedo Mera JC, Tovar Murillo SL, Cendales Duarte R. Cervical cytology in Soacha, Colombia: social representation, barriers and motivation. Rev Salud Púb (Bogotá) [Internet]. 2006 [citado 2 Nov 2016]; 8(3): [aprox. 3 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Cervical+cytology+in +Soacha%2C+Colombia%3A+social+representaci%C3%B3n%2C+b arriers+and+motivaci%C3%B3n

  6. Tsu VD1, Pollack AE. Preventing cervical cancer in low-resource settings: how far have we come and what does the future hold? Int J Gynaecol Obstet [Internet]. 2015 [citado 5 Nov 2016]; 89 (suppl 2): [aprox. 2 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Program+for+Appropr iate+Technology+in+Health+PATH+Planning+appropriate+cervical+ cancer+prevention+programs

  7. Cuadro 86. Programa de detección del cáncer cérvico - uterino. Mujeres examinadas según edad. 2007-2008. [citado 5 Nov] 2016. Disponible en: http://bvs.sld.cu/anuario/tablas/ANUARIOCU1.1- 2017.htm

  8. Cabezas Cruz E, Camacho Canino T, Santana Martínez A, Borrajero Martínez I, Aguilar Vela de Oro F, Romero Pérez T, et al. Programa Nacional de Diagnóstico precoz del Cáncer Cervicouterino. La Habana: Ciencias Médicas; 2000.

  9. Galán Y1, Fernández L, Torres P, García M. Trends in Cuba's Cancer Incidence (1990 to 2003) and Mortality (1990 to 2007). MEDICC Rev. [Internet]. 2009 [citado 5 Nov 2016]; 11(3):[aprox. 2 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Trends+in+Cuba%C2 %B4s+Cancer+Incidence+%281990+to+2003%29+and+mortality+ %281990+to+2007%29

  10. Gómez García L, González Sáez Y, Cáceres Pineda M A, Nápoles Camejo B, Téllez González R, Fabelo Bonet O. Caracterización de las pacientes con citología orgánica alterada. Rev Cub Obstet Gin [Internet]. 2012 Sep [citado 6 Dic 2016]; 38(3):378-388. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 600X2012000300010&lng=es

  11. Barbón Arnaldo. Análisis de algunos factores de riesgo de lesiones premalignas de cuello uterino en un área de salud. Rev Hab Cienc Méd [Internet]. 2009 Nov [citado 6 Dic 2016];8(4):[aprox. 20 p.]. Disponible en: http://scielo.sld.cu/pdf/rhcm/v8n4/rhcm05409.pdf

  12. Herrera Pérez MA, Cirión Martínez GR, Sanabria Negrín JG. Impacto de la capacitación en la mejora continua de la calidad del diagnóstico citológico. Rev Ciencias Med [Internet]. 2010 [citado 9 Nov 2016]; 14(1):[aprox. 29 p.]. Disponible en: http://scielo.sld.cu/pdf/rpr/v14n1/rpr09110.pdf

  13. Domínguez Jay N, Lugo Valdés Y. Cáncer de cuello uterino en pacientes ambulatorios en Venezuela. Comportamiento clínicoepidemiológico. RIC [Internet]. [citado 12 dic 2016. Disponible en: http://www.gtm.sld.cu/sitios/cpicm/contenido/ric/textos/vol_71_No.3 /comportamiento_clinico_epidem_cancer_cuello_tc.pdf

  14. Santana Serrano C, Chávez Roque M, Viñas Sifontes LN, Hernández López E, Cruz Pérez J. Diagnóstico precoz del cáncer cérvicouterino. Rev Cub Obst Gin [Internet]. 2011 [citado 12 Dic 2016]; 37(2):213- 222. Disponible en:http://scielo.sld.cu/pdf/gin/v37n2/gin11211.pdf

  15. Konno R, Sagae S, Yoshikawa H, BasuPS, Hanley SJ, Tan JH, Shin HR. Cervical Cancer Working Group report. Jpn J ClinOncol [Internet].2010 [citado 14 Dic 2016]; 40(Suppl 1):[aprox. 3 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Cervical+Cancer+Wor king+Group+report.+Japanese+Journal+Of+Clinical+Oncology.

  16. Sanjose S de, Quint WG, Alemany L, Geraets DT, Klaustermeier JE. Human papilloma virus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Lancet Oncol [Internet]. 2010 [citado 14 Dic 2016]; 11(11): [aprox. 12 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20952254




2020     |     www.medigraphic.com